LFA
BIIB icon

Legend Financial Advisors’s Biogen BIIB Stock Holding History

Legend Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$1.39K – 210
2023
Q1 		$1.39K Hold
5
– – ﹤0.01% 217
2022
Q4 		$1.39K Hold
5
– – ﹤0.01% 228
2022
Q3 		$1.33K Buy
+5
New +$1.06K ﹤0.01% 215

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Legend Financial Advisors's BIIB Position: Q2 2023 in Review

Legend Financial Advisors sold out of Biogen (BIIB) in Q2 2023, closing a stake of 5 shares — an estimated $1.39K sold.

Legend Financial Advisors first reported a position in BIIB in Q3 2022 and held it in 3 quarters. The position peaked at $1.39K in Q1 2023. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • Legend Financial Advisors reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
  • Legend Financial Advisors sold 5 Biogen shares in Q2 2023, an estimated $1.39K.
  • Legend Financial Advisors first reported a position in Biogen in Q3 2022 and held it in 3 quarters.
  • Legend Financial Advisors's Biogen position peaked at $1.39K in Q1 2023.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Legend Financial Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.